Hutch News
Results per Page:
Peripheral neuropathy: When having no pain is a big problem
Chemotherapy-induced nerve damage is common for cancer patients and difficult to treat
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 20, 2023
ASCO 2022: Equity, innovation and in-person
Hutch cancer researchers, clinicians share findings on clinical trial eligibility, Medicaid expansion, wearables to track symptoms and more
Tip Sheet: Massive unmet needs in COVID-19 treatment, osteoporosis drugs for breast cancer, new bladder cancer target — and AIDS at 40
Summaries of recent Fred Hutch research findings and other news
Fred Hutch researchers present virtually at the 2020 American Society of Clinical Oncology meeting
The latest findings on bladder cancer, pediatric cancer, gender disparities and the financial toxicity of cancer
How to talk to parents about HPV vaccines
Fred Hutch public health researcher shares science-based tips to help doctors navigate crucial cancer-prevention conversations
Breaking down HIV exclusions in cancer clinical trials
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
Fred Hutch at ASCO: HPV vaccine uptake in U.S., immunotherapy and sarcoma, financial toxicity of cancer, health care disparities and more
The American Society of Clinical Oncology will hold its annual meeting May 31-June 4 in Chicago
For cancer patients with HIV, immunotherapy appears safe
Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials